Minerva Neurosciences
NERV
21 hedge funds and large institutions have $55.1M invested in Minerva Neurosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
24% more funds holding
Funds holding: 17 → 21 (+4)
18% more capital invested
Capital invested by funds: $46.7M → $55.1M (+$8.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$339K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$189K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$172K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$83.1K |
| 5 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$52.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$85.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15K |
| 3 |
Walleye Trading
New York
|
-$1K |
| 4 |
Morgan Stanley
New York
|
-$292 |
NERV Hedge Fund Activity: Q4 2015 in Review
21 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2015, worth a combined $55.1M — up 18% from $46.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NERV positions and 1 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Highland Capital Management (Texas), adding an estimated $339K. The largest seller was Goldman Sachs, cutting an estimated $85.1K.
- 21 institutional investors held Minerva Neurosciences (NERV) as of Q4 2015, up from 17 in Q3 2015.
- Funds reported $55.1M of Minerva Neurosciences stock for Q4 2015, up 18% quarter-over-quarter.
- 5 funds opened new Minerva Neurosciences positions in Q4 2015 and 1 closed out, a net change of +4 holders.
- The largest Minerva Neurosciences buyer in Q4 2015 was Highland Capital Management (Texas), an estimated $339K added.
- The largest Minerva Neurosciences seller in Q4 2015 was Goldman Sachs, an estimated $85.1K sold.
Based on aggregated 13F filings for Q4 2015.